title: [Severe acute hepatitis induced by alendronate].
authors.forename: Christophe
authors.initials: C
authors.lastname: Carrère
authors.forename: Jean-Luc
authors.initials: JL
authors.lastname: Duval
authors.forename: Bruno
authors.initials: B
authors.lastname: Godard
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: De Jaureguiberry
authors.forename: Jean-Marc
authors.initials: JM
authors.lastname: Ciribilli
mesh_terms: D000368:Aged; D019386:Alendronate / Q000009:adverse effects* / Q000627:therapeutic use; D015519:Bone Density; D056486:Chemical and Drug Induced Liver Injury / Q000175:diagnosis / Q000209:etiology*; D005260:Female; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy
chemical_list: D019386:Alendronate
vernacular_title: Hépatite aiguë sévère imputable à l'alendronate.